A Phase I Study of IPI-145 in Patients with Advanced Hematologic Cancers [Protocol 12-088] |
Horwitz, Steven |
- Hematology
- Leukemia
- Lymphoma
|
A Phase I Study of Ipilimumab in Children, Adolescents, and Young Adults with Treatment-Refractory Cancer [Protocol 10-193] |
Wexler, Leonard |
- Lymphoma
- Hodgkin's Disease
- Non-Hodgkin's Lymphoma
- Melanoma
- Sarcomas
|
A Phase I Study of Iso-Fludelone in Patients with Advanced Solid Tumors [Protocol 10-202] |
Gounder, Mrinal |
|
A Phase I Study of KPT-330 in Patients with Advanced or Metastatic Solid Tumors [Protocol 12-258] |
Gerecitano, John |
|
A Phase I Study of LDE225 with Etoposide and Cisplatin for the Initial Treatment of Extensive Small Cell Lung Cancer [Protocol 11-206] |
Pietanza, M. Catherine |
- Lung Cancer
- Lung Cancer, Small Cell
|
A Phase I Study of LDK378 in Adults with Non-Small Cell Lung Cancers Containing an ALK Gene Fusion [Protocol 11-055] |
Riely, Gregory |
- Lung Cancer
- Lung Cancer, Non-Small Cell
|
A Phase I Study of LY3023414 in Patients with Advanced Cancer [Protocol 12-286] |
Hyman, David |
|
A Phase I Study of MED14736 in Patients with Advanced Solid Tumors [Protocol 12-179] |
Segal, Neil |
|
A Phase I Study of Modified T Cells Targeted to CD19-Positive Acute Lymphoblastic Leukemia Relapsing After Allogeneic Stem Cell Transplantation [Protocol 11-038] |
Kernan, Nancy |
- Leukemia
- Acute Lymphoblastic Leukemia
|
A Phase I Study of MORAb-004 in Patients with Solid Tumors [Protocol 10-012] |
Carvajal, Richard |
|
A Phase I Study of Narnatumab (IMC-RON8) in Patients with Refractory Solid Tumors [Protocol 13-018] |
Gounder, Mrinal |
|
A Phase I Study of Oral DS-7423 in Patients with Advanced Solid Tumors [Protocol 11-144] |
Ho, Alan |
|
A Phase I Study of Oral LEE011 in Patients with Advanced Solid Tumors or Lymphomas [Protocol 10-211] |
Gerecitano, John |
|
A Phase I Study of Panitumumab in Children with Solid Tumors [Protocol 08-020] |
Meyers, Paul |
|
A Phase I Study of Pegylated Liposomal Doxorubicin, Carboplatin, and Veliparib in Recurrent Ovarian, Primary Peritoneal, and Fallopian Tube Cancer [Protocol 12-197] |
Bell-McGuinn, Katherine |
|
A Phase I Study of PF-05082566 Alone in Patients with Advanced Cancer, and in Combination with Rituximab in Patients with Non-Hodgkin Lymphoma [Protocol 11-085] |
Segal, Neil |
|
A Phase I Study of Plerixafor as a Chemosensitizing Agent for Children with Relapsed Acute Leukemia or Myelodysplastic Syndromes [Protocol 11-208] |
Trippett, Tanya |
- Hematology
- Leukemia
- Acute Lymphoblastic Leukemia
- Acute Myelogenous Leukemia
- Myelodysplastic Syndrome
|
A Phase I Study of PLX3397 in Patients with Advanced Solid Tumors [Protocol 12-156] |
Tap, William |
|
A Phase I Study of PU-H71 in Patients with Advanced Cancer [Protocol 11-041] |
Gerecitano, John |
|
A Phase I Study of SGN-CD19A in Patients with Relapsed or Refractory Non-Hodgkin Lymphoma [Protocol 12-282] |
Moskowitz, Craig |
|